look news india
In the coming times, the need to wear glasses may end. A new eye medicine has brought a revolution. Mumbai-based company Antod Pharmaceuticals has launched Preview Eye Drops which treats presbyopia. Presbyopia is a condition in which people have difficulty focusing on nearby objects. Around 109 to 180 crore people around the world suffer from this problem. Presbyopia usually starts after the age of 40 and continues to increase till the age of 60
Antode Pharmaceuticals has received final approval from the Drug Controller General of India (DCGI). Earlier, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the product. Preview is the first eye medicine in India that can reduce the need for reading glasses for people suffering from presbyopia. It is a common age-related vision problem that affects people above 40 years of age.
Patent application for unique formulation
Antode Pharmaceuticals has applied for a patent for this unique formulation and its manufacturing process. This proprietary formulation not only eliminates the need for reading glasses, but also provides the added benefit of lubricating the eyes.
cutting edge technology
Pressview eye drops feature an advanced dynamic buffer technology, which allows them to rapidly adapt to the pH of tears, ensuring continued efficacy and safety for long-term use. Since these drops can be used for years, this feature is particularly important.
This can significantly affect
Daily life and productivity. Preview offers a non-invasive option for people over 40 who may notice this condition when they start reading material at arm's length.
Nikhil K. Masurkar, CEO, Antode Pharmaceuticals,
Highlighting the significance of this acknowledgment, he said that PressView is the result of years of dedicated research and development. PressView is not just a product; it is a solution that stands to improve the lives of millions of people, giving them greater visual freedom.
how much will it cost ,
Dr Aditya Sethi said that Presview can provide an advanced option that improves near vision within 15 minutes. From the first week of October, the prescription-based eye drug will be available in pharmacies at a price of Rs 350. The drug is for the treatment of mild to moderate presbyopia in individuals aged 40 to 55 years.